SCHEMBL17166365

SCHEMBL17166365

Cc1ccc(N[C@H]2CCC[C@@H]2NC(=O)c2ccccc2-n2nccn2)nc1

nearest known ligand 0.79

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HCRTR1 O43613 19/20 0.79
HCRTR2 O43614 4/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17017370 1.00 HCRTR1 (0.79) HCRTR1HCRTR2
SCHEMBL17166370 0.89 HCRTR1 (0.76) HCRTR1HCRTR2
SCHEMBL17017364 0.89 HCRTR1 (0.85) HCRTR1HCRTR2
SCHEMBL17166369 0.89 HCRTR1 (0.78) HCRTR1HCRTR2
SCHEMBL17017384 0.89 HCRTR1 (0.76) HCRTR1HCRTR2
SCHEMBL17017377 0.89 HCRTR1 (0.78) HCRTR1HCRTR2
SCHEMBL17028094 0.88 HCRTR1 (1.00) HCRTR1HCRTR2
SCHEMBL17007231 0.88 HCRTR1 (1.00) HCRTR1HCRTR2
SCHEMBL17017464 0.87 HCRTR1 (0.78) HCRTR1HCRTR2
SCHEMBL17166363 0.87 HCRTR1 (0.75) HCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9156829-B2 Cycloalkyl and heterocycloalkyl compounds as orexin receptor antagonists TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2015-10-13 US disclosed